期刊文献+

红霉素联合索利那新治疗女性急性膀胱炎的临床观察 被引量:1

下载PDF
导出
摘要 目的观察红霉素联合索利那新治疗女性急性膀胱炎的效果和副作用。方法共入组248例急性膀胱炎女性患者,年龄18~75岁,随机分为两组,对照组136例,服用红霉素0.5 g,3次/d;联合组112例,服用红霉素0.5 g,3次/d+索利那新5 mg,1次/d。治疗5 d后,比较两组膀胱过度活动症(OAB)症状评分和疼痛评分(VAS),观察药物的副作用。结果治疗后,两组症状评分都逐渐降低,但是联合组的症状改善更快、更好(P〈0.05);治疗5 d后,联合组有8例(7.10%)尿白细胞阳性,而对照组有28例(20.60%),两组比较有显著差异(P〈0.05);联合组有8例(7.10%)口干,4例(3.60%)视物模糊,8例(7.10%)排尿困难,但是均很轻微,无需停药。结论与单独采用红霉素治疗比较,采用红霉素联合索利那新治疗女性急性膀胱炎效果更好,且副作用轻微。
出处 《西南国防医药》 CAS 2015年第8期881-883,共3页 Medical Journal of National Defending Forces in Southwest China
  • 引文网络
  • 相关文献

参考文献10

  • 1Car J. Urinary tract infections in women: diagnosis and management in primary care[J]. BM.I, 2006, 332(7533):94-97.
  • 2Vogel T, Verreault R, Gourdeau M, et al. Optimal duration of antibiotic therapy for uncomplicated urinary tract infection in older women: a double-blind randomized controlled trial [J]. CMAJ, 2004, 170:469-473.
  • 3Hessdoerfer E, Jundt K, Peschers U. Is a dipstick test sufficient to exclude urinary tract infection in women with overactive bladder[J]? Int Urogynecol J, 2011, 22(2):229-232.
  • 4Chapple CR, Cardozo L, Steers WD, et al. Solifenacin significantly improves all symptoms of overactive bladder syndrome[J]. Int J Clin Pract, 2006, 60(8): 959-966.
  • 5Kersten P, White PJ, Tennant A. The visual analogue WOMAC 3.0 scale-internal validity and responsiveness of the VAS version [J]. BMC Musculoskelet Disord, 2010, 30(11):80.
  • 6Sehmiemann G, Kniehl E, Gebhardt K, et al. The diagnosis of urinary tract infection: a systematic review [J]. Dtsch Arztebl Int, 2010, 107(21):361-367.
  • 7Knottnerus BJ, Bindels PJ, Geerlings SE, et al. Optimizing the diagnostic work-up of acute uncomplicated urinary tract infections[J]. BMC Fam Pract, 2008, 8: 59-64.
  • 8Little P, Merriman R, Turner S, et al. Presentation, pattern, and natural course of severe symptoms, and role of antibiotics and antibiotic resistance among patients presenting with suspected uncomplicated urinary tract infection in primary care: observational study[J]. BMJ,2010, 5:340.
  • 9Choo MS, Lee JZ, Lee JB, et al. Efficacy and safety of solifenacin succinate in Korean patients with overactive bladder: a randomised, prospective, double-blind, multicentre study[J]. Int J Clin Pract, 2008, 62(11):1675-1683.
  • 10Yoshida M, Masunaga K, Nagata T, et 81. The forefront for novel therapeutic agents based on the pathophysiology of lower urinary tract dysfunction: pathophysiology and pharmacotherapy of overactive bladder[J]. J Pharmacol Sci, 2010, 112(2): 128-134.

同被引文献6

引证文献1

;
使用帮助 返回顶部